LWAY vs MAGN
Valuation
Profitability
Growth
Financial Health
Dividends
AI Verdict
LWAY exhibits a weak Piotroski F-Score of 3/9, indicating deteriorating fundamental health despite a clean balance sheet. The stock is trading at a severe premium to both its Graham Number ($10.62) and Intrinsic Value ($6.23), suggesting the current price of $24.40 is speculative. While revenue growth is strong at 18%, consistent earnings misses and aggressive insider selling signal a lack of confidence in the current valuation.
MAGN exhibits severe financial distress as evidenced by a weak Piotroski F-Score of 2/9, indicating a deteriorating fundamental position. While the stock appears deeply undervalued on a Price-to-Book (0.34) and Price-to-Sales (0.11) basis, these metrics are offset by negative ROE (-12.41%) and a catastrophic 5-year price decline of 94.5%. The company's earnings track record is abysmal, with zero beats in the last four quarters and massive negative surprises. Despite a healthy current ratio, the high debt-to-equity ratio and consistent operational misses suggest a value trap rather than a recovery play.
Compare Another Pair
Related Comparisons
LWAY vs MAGN: Head-to-Head Comparison
This page compares Lifeway Foods, Inc. (LWAY) and Magnera Corporation (MAGN) across key fundamental metrics including valuation ratios, profitability margins, growth rates, financial health indicators, and dividend metrics. Each metric highlights the better-performing stock so you can quickly identify relative strengths and weaknesses.
Our AI engine independently analyzes each company's financials, competitive position, and market conditions to produce a verdict (Bullish, Neutral, or Bearish) along with key strengths and risks. Use this comparison alongside your own research to make informed investment decisions.